17.68 -0.08 (-0.45%)
MYL
Stock Details
Last Trade:17.68 Change:-0.08 (-0.45%) Prev Close:17.76 Open: 17.80 Days Range:17.54 – 17.96 52 Week Range: 11.14 - 19.21 Volume:5953376 P/E: 110.50EPS:0.16
View AllRecent Alerts 02/10/10
Recent Alert on 02/03/10 at 7:44am
Oppenheimer Starts Mylan (MYL), Warner Chilcott (WCRX) at Outperform
Oppenheimer Starts Mylan (MYL), Warner Chilcott (WCRX) at Outperform
An analyst at Oppenheimer has initiated coverage on two stocks in the Biotech and Drugs sector this morning, both with Outperform ratings: Mylan (NYSE: MYL) with a $24 price target Warner Chilcott (Nasdaq: WCRX) with a $33 price target
Recent Alert on 01/29/10 at 10:43am
Mylan (MYL) Gets OK from U.S. FDA for ANDA for Generic Form of GoLytely
Mylan (MYL) Gets OK from U.S. FDA for ANDA for Generic Form of GoLytely
Recent Alert on 01/29/10 at 10:43am
Mylan (MYL) Gets OK from U.S. FDA for ANDA for Generic Form of GoLytely
Mylan (MYL) Gets OK from U.S. FDA for ANDA for Generic Form of GoLytely
Recent Alert on 01/08/10 at 10:51am
Notable Analyst Rating Changes 1/8: HAL, AMAT, JCP, AGU, ESV, RDN, More Upgraded; M, KO, STX, ERIC, WEN, PCS, More Downgraded
Notable Analyst Rating Changes 1/8: HAL, AMAT, JCP, AGU, ESV, RDN, More Upgraded; M, KO, STX, ERIC, WEN, PCS, More Downgraded
Recent Alert on 01/08/10 at 8:37am
Mylan (MYL) Pre-Paid $196M in Term-Loans Due 2011; Has No Term-Loan Obligations Due in 2012
Mylan (MYL) Pre-Paid $196M in Term-Loans Due 2011; Has No Term-Loan Obligations Due in 2012
View AllRecent Press Releases
Press Release on 02/09/10 at 6:38pm
Mylan Awarded NABP-VAWD Accreditation for Its Primary North American Distribution Facility
Mylan Awarded NABP-VAWD Accreditation for Its Primary North American Distribution Facility
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 02/03/10 at 11:15am
Analyst Upgrades, Downgrades and Initiations: ARM, KFT, LOW, OXY, UBS, UPS, VRSN ...
Analyst Upgrades, Downgrades and Initiations: ARM, KFT, LOW, OXY, UBS, UPS, VRSN ...
Blog Posts on 12/29/09 at 4:18am
Watson Pharmaceuticals: Look-Ahead to December 2009 Quarterly Results
Watson Pharmaceuticals: Look-Ahead to December 2009 Quarterly Results